Status:
UNKNOWN
Effect of Prophylactic Medical Compression Therapy on the Reduction of Breast Cancer-related Lymphedema in Patients With Adjuvant Docetaxel Chemotherapy: a Randomized Controlled Study
Lead Sponsor:
Samsung Medical Center
Conditions:
Breast Cancer Lymphedema
Eligibility:
All Genders
19-70 years
Phase:
NA
Brief Summary
In this study, the purpose of this study is to investigate whether prophylactic medical compression therapy in breast cancer patients receiving docetaxel adjuvant chemotherapy could reduce the inciden...
Eligibility Criteria
Inclusion
- Patients who underwent radical mastectomy and sentinel lymphctomy or axillary lymphectomy after diagnosis of unilateral breast cancer
- Patients who are scheduled for adjuvant chemotherapy including Docetaxel after surgery
- Patients aged 19 to 70
- Patients who can understand the contents of this study and obtain consent
Exclusion
- Patients with a history of breast-related surgery prior to this breast cancer surgery
- Patients with metastases to other organs
- Patients who have undergone neoadjuvant chemotherapy or have previously received radiation therapy
- Patients with systemic diseases that may not be able to conduct clinical research
- Patients with skin diseases who cannot receive medical compression treatment
Key Trial Info
Start Date :
March 12 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04787029
Start Date
March 12 2021
End Date
December 30 2025
Last Update
October 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea